← Back to all signals
RESEARCH PAPER ANALYSIS

Clinical Risk Factors and Outcomes of Spontaneous Hepatoblastoma Rupture in Children: A 10-Year Propensity Score-Matched Study.

In a single-center retrospective propensity score-matched cohort, spontaneous hepatoblastoma rupture was associated with larger tumors, advanced local disease, macrovascular invasion, and worse overall and event-free survival in children.

Open original publication →
PMID42795879
JournalJournal of clinical medicine
Publication Date2026-09-13
Ingested2026-09-28 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

In a single-center retrospective propensity score-matched cohort, spontaneous hepatoblastoma rupture was associated with larger tumors, advanced local disease, macrovascular invasion, and worse overall and event-free survival in children.

WHY IT MATTERS

Research significance

The study provides observational evidence that tumor size and macrovascular invasion may flag children at elevated risk of spontaneous rupture; it is an untested inference that using these features for intensified surveillance or earlier multidisciplinary planning could prevent rupture-related complications or improve outcomes.

ABSTRACT

Source abstract

Background: Spontaneous rupture of hepatoblastoma is uncommon but potentially fatal in children. Published cohorts often combine spontaneous, traumatic, biopsy-related, and treatment-associated events. We aimed to identify clinical risk factors for spontaneous rupture and evaluate its prognostic impact. Methods: We retrospectively reviewed 106 children with pathologically confirmed hepatoblastoma treated at a tertiary center from July 2010 to July 2020. After excluding 10 with incomplete data or follow-up, 96 were eligible. Fourteen children who presented with spontaneous rupture were included in the rupture group. Eighty-two children without rupture were eligible as controls, and 42 were selected after 1:3 propensity score matching for age, sex, height, and weight. Subsequent analyses were restricted to the 1:3 propensity score-matched cohort. However, the matched-set identifier was not incorporated into the group comparisons, regression models, or survival analyses. Rupture was diagnosed by contrast-enhanced imaging and/or intraoperative findings. Logistic regression was used to identify independent risk factors. Exploratory two-predictor ridge regression and 2000-bootstrap internal validation were used to examine maximum tumor diameter and macrovascular invasion. Overall survival (OS) and event-free survival (EFS) were estimated using Kaplan-Meier analysis. Results: The rupture group had lower hemoglobin levels, larger tumors, more frequent bilobar disease, higher PRETEXT stage, and substantially more vascular invasion. Exploratory multivariable analysis suggested associations of maximum tumor diameter (OR 3.078, 95% CI 1.62-5.55) and macrovascular invasion (OR 13.521, 95% CI 1.16-148.23) with rupture. Given the small number of rupture events and the wide confidence interval for macrovascular invasion, these estimates should be interpreted cautiously and not as confirmation of independent risk factors. Macrovascular invasion was associated with rupture in crude analysis (odds ratio 8.00, 95% confidence interval 2.05-31.16) and the exploratory ridge model (adjusted odds ratio 2.89, 95% bootstrap confidence interval 1.27-7.93). The combined model incorporating maximum tumor diameter and macrovascular invasion showed an apparent area under the curve of 0.930 and an optimism-corrected area under the curve of 0.924. Children with ruptures had significantly worse OS and EFS than matched controls. Conclusions: Spontaneous rupture was associated with a clinically aggressive presentation characterized by substantially larger tumors, advanced local disease, and more frequent macrovascular invasion, and affected children had markedly lower OS and EFS estimates than matched controls. The results support tumor burden and macrovascular invasion as clinically relevant warning features that may help identify children requiring closer surveillance and early multidisciplinary planning.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Serological Evaluation of Anti- FSH Antibody and Anti- LH antibody In Iraqi Women with Polycystic Ovarian Syndrome. F1000Research 62.66 2 Deaths: Leading Causes for 2024. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 57.5 3 Association between hematopoietic recovery indicators and minimal residual disease after induction therapy in newly diagnosed pediatric acute myeloid leukemia. Frontiers in medicine 64.74 4 Methylprednisolone sodium succinate combined with azithromycin in the treatment of Mycoplasma pneumonia in children and Its effect on immune function. Frontiers in pediatrics 67.54 5 Potential of isotoxic dose escalation with robustly optimized VMAT and IMPT for large hepatocellular carcinoma according to baseline liver function. Journal of applied clinical medical physics 80.42 6 Lifestyle Behaviors and Physical Health in Canadian Childhood, Adolescent, and Young Adult Cancer Survivors. Cancer medicine 58.7 7 Assessment of Selected Immunophenotypic Markers in Childhood Non-Hodgkin's Lymphomas in Ghana: A Possible Tool for Effective Stratification of Patients and Assessment of Survival Outcomes. Cancer reports (Hoboken, N.J.) 70.02 8 Establishing environmental causes of childhood cancer: a view from the IARC Monographs. UCL open. Environment 63.0 9 Chatbot Intervention and Cancer Risk Knowledge in Adolescents and Young Adults With Cancer Predisposition: A Randomized Clinical Trial. JAMA network open 73.7 10 Qualitative Exploration of Fertility-Related Attitudes and Perspectives Among Young Adult Women Diagnosed With Breast Cancer at Periurban Cancer Center in Uganda. JCO global oncology 61.1 11 Rare aetiologies of leg ulcers: a prospective analysis. Journal of wound care 65.8 12 Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study. European journal of cancer (Oxford, England : 1990) 71.54 13 Rapid Whole Genome Sequencing Enhances Pediatric Cancer Diagnosis. Nature communications 66.6 14 Cardiopulmonary exercise testing to measure cardiorespiratory fitness in childhood cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 47.5 15 Age- and latency-specific patterns of subsequent malignant brain and other nervous system tumors after cancer diagnosed before age 40 years. Cancer causes & control : CCC 56.0 16 Impact of Extent of Surgical Resection on Survival in Patients With High-risk Neuroblastoma: A Report From Children's Oncology Group ANBL0532. Annals of surgery 71.72 17 Routine Serologic Duffy Testing in Pediatric Oncology: Clinical Utility and Feasibility in a Single-Center Cohort. Pediatric blood & cancer 79.0 18 Exercise Capacity, Physical Activity, Fatigue, and Neurocognitive Function in Adult Survivors of Childhood Acute Lymphoblastic Leukemia. Pediatric blood & cancer 61.0 19 "We Cannot Talk as a Family": Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians. Pediatric blood & cancer 59.6 20 Textbook Outcome in Pediatric Nephroblastoma Surgery After Neoadjuvant Chemotherapy: Defining Standards, Introducing Near-Miss, and Predictors of Failure. Pediatric blood & cancer 73.54 21 Parents of Youth With Cancer Report on Their Psychosocial Care: iSTEPPP Survey Finds Alignment and Gaps With Standards. Pediatric blood & cancer 61.9 22 Skipping of Exon 38 in Neurofibromatosis Type 1 Gene Is Not a Pathogenic Variant. Pediatric blood & cancer 54.0 23 Evidence-Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource-Sensitive Recommendations for the Asian Continent. Pediatric blood & cancer 67.4 24 Obesity's Impact on Prognosis in Ph-Like Acute Lymphoblastic Leukemia. Pediatric blood & cancer 61.2 25 Occupation and Lymphoma Risk by Cell of Origin: A Nationwide Matched Case-Control Study in Thailand. Cancer prevention research (Philadelphia, Pa.) 69.0 26 Cardioneuromodulation for Recurrent Malignant Neurocardiogenic Syncope in Pediatric Patients: Results from a Tertiary Center. Pediatric cardiology 61.5 27 Invasive Pneumococcal Disease in Children: A Retrospective Three-Center Study in Zhejiang Province, China (2010-2024). Infectious diseases and therapy 66.1 28 Speciation-informed Bayesian assessment of metal(loid) exposure from Akora River fish, Ghana, for consumption guidance. Environmental monitoring and assessment 58.4 29 Clinical characteristics, anatomical distribution, and diagnostic patterns of simple bone cysts in Japan: an analysis of the Japanese Bone and Soft Tissue Tumor registry. International journal of clinical oncology 66.9 30 Pathological fracture as initial manifestation of malignancy and survival based on diagnoses: a register-based cohort study from the Swedish Fracture Register and the Swedish Cancer Register. Acta orthopaedica 66.52 31 Melanoma Prevention Among Children of Melanoma Survivors: A Randomized Clinical Trial. JAMA dermatology 78.0 32 Causal estimation and machine learning methods for survival outcomes among AYA cancer patients: A scoping review. Cancer epidemiology 67.02
PATIENT-FRIENDLY SUMMARY

Clinical Risk Factors and Outcomes of Spontaneous Hepatoblastoma Rupture in Children: A 10-Year Propensity Score-Matched Study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic